Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 2"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject&page=10
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject&page=10
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject&page=10
PubPharm (124.538)
91
Phase 2 Study of DKN-01 in Colorectal Cancer : Randomized Phase 2 Study of DKN-01 Plus FOLFIRI/FOLFOX and Bevacizumab Versus FOLFIRI/FOLFOX and Bevacizumab as Second-line Treatment of Advanced Colorectal Cancer (DeFianCe)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
92
Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trials : A Long-term Extension Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Subcutaneous Amlitelimab in Participants of Previous Amlitelimab Clinical Trials in Moderate to Severe Atopic Dermatitis.
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
93
Extension Study (Extended Access) of Syk-inhibition Using Fostamatinib to Treat Posttransplant Immune-mediated Cytopenias : Extension Study (Extended Access) of Syk-inhibition Using Fostamatinib to Treat Post-Transplant Immune-mediated Cytopenias
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
94
Osimertinib to Suppress the Progression of Remaining GGN for EGFR Mutation-positive Stage IB-IIIA Lung Adenocarcinoma : A Phase II Study of Osimertinib to Suppress the Progression of Remaining Ground-glass Opacity Nodule (GGN) for Actionable EGFR Mutation-positive Stage IB-IIIA Lung Adenocarcinoma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
95
Safety and Efficacy of Intravenous Cemiplimab Plus BNT116 Versus Cemiplimab Alone in Advanced Non-Small Cell Lung Cancer in Adult Participants With PD-L1 ≥ 50% : A Phase 2 Study of Cemiplimab (Anti-PD-1 Antibody) in Combination With BNT116 (FixVac Lung) Versus Cemiplimab Monotherapy in First-Line Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) With Tumors Expressing PD-L1 ≥50%
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
96
CD30 CAR for CD30+ NSGCT : Administration of T Lymphocytes Expressing the CD30 Chimeric Antigen Receptor (CAR) for Patients With CD30+ Nonseminomatous Germ Cell Tumors (NSGCT)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
97
Early Metabolic Effects of Dolutegravir or Tenofovir Alefenamide in Healthy Volunteers : A Phase 2 Randomized Cross-Over Design Study of the Early Metabolic Effects of Dolutegravir or Tenofovir Alafenamide in Healthy Volunteers
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
98
Transcranial Magnetic Stimulation for Youth With Treatment-Resistant Major Depressive Disorder : An Open Trial of Transcranial Magnetic Stimulation for Youth With Treatment-Resistant Major Depressive Disorder
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
99
A Study of VGL101 in Patients With Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia : A Phase 2 Safety, Tolerability, and Proof-of-Concept Study of VGL101 in Patients With Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia (ALSP) (The Ignite Study)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
100
Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort : Integrating Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort (INSIGHT)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
[1]
« Vorheriger
5
6
7
8
9
10
11
12
13
14
15
Nächster »
[12454]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Phase: Phase 2
Medienart
124.538
Aufsätze
124.538
E-Artikel
124.538
E-Ressourcen
Zeitschriftentitel
70.970
WHO International Clinical Trials Registry Plat...
53.568
ClinicalTrials.gov
Thema
124.538
610
Phase: Phase 2
124.508
Study Type: Interventional
39.939
Recruitment Status: Not yet recruiting
31.725
Recruitment Status: Completed
15.068
Recruitment Status: Authorised-recruitment may ...
14.913
Recruitment Status: Recruiting
5.825
Recruitment Status: Terminated
4.478
Recruitment Status: Active, not recruiting
3.794
Recruitment Status: Complete: follow-up complete
3.263
Recruitment Status: Unknown status
3.034
Carcinoma
2.491
Breast Neoplasms
2.269
Recruitment Status: Withdrawn
1.970
Lung Neoplasms
1.936
Lymphoma
1.838
Carcinoma, Non-Small-Cell Lung
1.624
Leukemia
1.446
Syndrome
1.303
Prostatic Neoplasms
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
79.371
2020-
43.392
2010-2019
1.775
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
122.868
Englisch
860
Unbestimmt
422
Spanisch
182
Französisch
64
Deutsch
40
Dänisch
22
Italienisch
20
Sanskrit
12
Niederländisch
6
Schwedisch
4
Esperanto
4
Finnisch
4
Latein
4
Norwegisch
4
Portugiesisch
2
Corsican
2
Tschechisch
2
Estnisch
2
Frisian
2
Galizisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...